Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(CSE:
EMH
)
N/A
UNCHANGED
Last Price
Updated: 1:23 PM EST, Nov 9, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.0050 (867,000)
Ask (Size)
0.8000 (17,000)
Prev. Close
0.0350
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
November 10, 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
October 18, 2022
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Via
Newsfile
Performance
More News
Read More
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
September 30, 2022
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
August 31, 2022
Via
Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
August 26, 2022
Via
Newsfile
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
August 19, 2022
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
July 11, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
July 04, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Rainbow Washing: How Insincere Branding Tarnishes Pride And Similar Celebrations Of Communities
June 21, 2022
Via
Benzinga
A Brief Overview: How Cannabis And LGBTQ Rights Reform Have Intertwined Through The Decades
May 31, 2022
Via
Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
May 12, 2022
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
Emerald Health Therapeutics Sells Patents to FlowerPod
January 11, 2022
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
November 29, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
November 29, 2021
Via
Newsfile
Topics
Cannabis
Exposures
COVID-19
Cannabis
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
November 03, 2021
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health's Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis Vaporizer
October 28, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
October 28, 2021
Via
Newsfile
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Emerald Health Therapeutics Announces Chief Financial Officer Transition
September 10, 2021
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
August 31, 2021
Via
Newsfile
Topics
Cannabis
Intellectual Property
Product Recall
Exposures
COVID-19
Cannabis
Intellectual Property
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
August 25, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Comments on Board Resignation
August 11, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Hires VP Sales & Marketing
August 10, 2021
Via
Newsfile
Topics
Cannabis
Supply Chain
Exposures
COVID-19
Cannabis
Supply Chain
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
August 06, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
July 23, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Emerald Health Therapeutics Launches Fuse(TM) Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage
July 21, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.